Health Care & Life Sciences » Pharmaceuticals | Pernix Therapeutics Holdings Inc.

Pernix Therapeutics Holdings Inc. | Mutual Funds

Mutual Funds that own Pernix Therapeutics Holdings Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total Stock Market Index Fund
276,171
1.98%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
90,003
0.65%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
33,331
0.24%
0
0%
09/06/2018
iShares Micro Cap ETF
32,196
0.23%
0
0%
09/06/2018
Fidelity Spartan Extended Market Index Fund
30,899
0.22%
0
0%
07/31/2018
Fidelity Nasdaq Composite Index
12,118
0.09%
0
0%
07/31/2018
11,772
0.09%
11,772
0%
12/31/2016
Vanguard Balanced Index Fund
4,399
0.03%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
4,109
0.03%
0
0%
07/31/2018
2,995
0.02%
0
0.01%
09/05/2018

About Pernix Therapeutics Holdings

View Profile
Address
10 North Park Place
Morristown New Jersey 07960
United States
Employees -
Website http://www.pernixtx.com
Updated 09/14/2018
Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.